Back Login to subscribe 🔔 Set Alert

PHAR Pharming Group N.V. ADS, each representing 10 ordinary shares

15 min delay
Today's News Sentiment
Loading...
Upcoming Earnings
Loading...
PHAR Fundamental Data
Loading...
Similar Companies
Loading...
PHAR Options Chain
Put/Call Ratio
-
-
Expected Move
-
-
Max Pain
-
-
ATM Call Break-even
-
-
ATM Put Break-even
-
-
Loading options…
CALLS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PUTS
Strike Last Bid Ask Mark IV Volume OI Δ Delta Θ Theta
PHAR Insider Transactions
Loading insider data…
PHAR News
Date Headline Sentiment
Pharming Group shares are trading higher after the company announced the commercial launch of Joenja in Japan for adult and pediatric patients with activated PI3K delta syndrome aged 4 years and older.
95.21%
Pharming Launches Joenja (Leniolisib) in Japan for APDS Patients Aged 4 and Older, Marking First Global Launch for Children 4 To 11
87.54%
Canaccord Genuity Maintains Buy on Pharming, Raises Price Target to $38
83.53%